Public signalVenture fundAuto-indexed · Unverified

AVSF - Cytovale 2024, LLC raised $652K

AVSF - Cytovale 2024, LLC· Boston, US· Pooled Investment Fund· Filed Oct 28, 2024

AVSF - Cytovale 2024, LLC is an investment fund that reported raising capital. Based in Boston, MASSACHUSETTS, US. First sale reported 2024-10-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$652,027
Confidence80%
Raised
$652,027
Investors
55
Incorporated
2024
Jurisdiction
DELAWARE

On the record

Location
Boston, US
Sector
Pooled Investment Fund
Record type
Venture fund
Stage
Reported raised
Amount raised
$652,027
Target amount
$652,027
Filing date
Oct 28, 2024
Issuer type
pooled investment fund

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2024
Industry group
Pooled Investment Fund
Fund type
Venture Capital Fund
Number of investors
55
Includes non-accredited investors
No
Revenue range
$1 - $1,000,000
Total offering amount
$652,027
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Investment fund raising capital, not an operating company round.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Oct 28, 2024. Details beyond the filing have not been verified.

Tags

USVenture Capital Fund fundFundPooled Investment Fund$100K – $1MVenture Fund

Are you associated with AVSF - Cytovale 2024, LLC?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record